Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland

Transfusion Medicine and Hemotherapy

Volumn 43, Issue 3, 2016, Pages 169-176

  Niederhauser, Christoph ^a   Gottschalk, Jochen ^b   Tinguely, Caroline ^a  

^a Blood Transfusion Service SRC Berne   (Switzerland)

^b Blood Center Zürich   (Switzerland)

Author keywords

Chagas; Malaria; Plasmodium spp; Selective testing; Trypanosoma cruzi

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHAGAS DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; PATIENT COUNSELING; PLASMODIUM; PRACTICE GUIDELINE; SWITZERLAND; TRYPANOSOMA CRUZI;

EID: 84966333741     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000446218     Document Type: Article

References (61)

1. Rassi A Jr, Rassi A, Marcondes de Rezende J: American trypanosomiasis (Chagas disease). Infect Dis Clin North Am 2012; 26: 275-291.
2. World Health Organization: First WHO Report On Neglected Tropical Diseases: Working of Overcome the Global impact of Neglected Tropical Diseases (WHO/HTM/NTD/2010.1) 2010 (cited 2012 March 20); Available from http://whqlibdoc.who.int/publications/2010/9789241564090-eng.pdf (last accessed April 19, 2016).
3. Piron M, Vergés M, Munõz J, Casamitjana N, Sanz S, Maymó RM, Hernández JM, Puig L, Portús M, Gascón J, Sauleda S: Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 2008; 48: 1862-1868.
4. Benjamin RJ, Stramer SL, Leiby DA, Dodd RY, Fearon M, Castro E: Trypanosma cruzi infection in North America and Spain: evidence in support of transfusion transmission. Transfusion 2012; 52: 1913-1921.
5. Strasen J, Williams T, Ertl G, Zoller T, Stich A, Ritter O: Epidemiology of Chagas disease in Europe: many calculations, little knowledge. Clin Res Cardiol 2014; 1031: 1-10.
6. Schmunis GA: Epidemiology of Chagas disease in nonendemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007; 102(suppl 1):75-85.
7. Wendel S, Gonzaga AL: Chagas' disease and blood transfusion: a New World problem? Vox Sang 1993; 64: 1-12.
8. Pedreira De Freitas JL, Amato Neto V, Sonntag R, Biancalana A, Nussenzveig V, Barreto JG: First tests on the accidental transmission of Chagas disease to man by blood transfusion. Rev Paul Med 1952; 40: 36-40.
9. Wendel S: Transfusion-transmitted Chagas' disease. Curr Opin Hematol 1998; 5: 406-411.
10. Hernandez-Becerril N, Mejia AM, Ballinas-Verdugo MA, Garza-Murillo V, Manilla-Toquero E, Lopez R, Trevethan S, Cardenas M, Reyes PA, Hirayama K, Monteon VM: Blood transfusion and iatrogenic risks in Mexico City. Anti-Trypanosma cruzi seroprevalence in 43,048 blood donor, evaluation of parasitemia and electrocardiogram findings in seropositive. Mem Inst Oswaldo Cruz 2005; 100: 111-116.
11. Castro E: Chagas disease: lessons from routine donations testing. Transfus Med 2009; 19: 16-23.
12. Menitove JE, Bennett JL: Lessons learned from Trypansoma cruzi test implementation. Transfusion 2012; 52: 1849-1851.
13. Schmunis GA: Prevention of transfusional Trypanosoma cruzi infection in Latin America. Mem Inst Oswaldo Cruz 1999; 94: 93-101.
14. Leiby DA, Herron RM, Read BA, Lenes BA, Stumpf RJ: Trypanosoma cruzi infection in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002; 4: 549-555.
15. Kirchhoff LV, Paredes P, Lomeli-Guerrero A, Paredes-Espinoza M, Ron-Guerrero CS, Delgado-Mejia M, Pena-Munoz JG: Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico; implications for transfusion medicine in the United States. Transfusion 2006; 46: 298-304.
16. Schmunis GA: Trypanosoma cruzi, the etiological agent of Chagas disease: status in the blood supply in endemic and nonendemic countries. Transfusion 1991; 31: 547-557.
17. Angheben A. Boix L, Buonfrate D, Gobbi F, Bisoffi Z, Pupella S, Gandini G, Aprili G: Chagas disease and transfusion medicine : a perspective from a non-endemic countries. Blood Transfus 2015; 13: 540-550.
18. Kitchen AS, Hewitt PE, Chiodini PL: The early implementation of Trypanosma cruzi antibody screening of donors and donations within England: pre-empting a problem. Transfusion 2012; 52: 1931-1919.
19. O'Brien SF, Delage G, Seed CR, Pillonel J, Fabra CC, Davison K, Kitchen A, Steele WR, Leiby DA: The epidemiology of imported malaria and transfusion policy in 5 nonendemic countries. Transfus Med Rev 2015; 29: 162-171.
20. O'Brien SF, Scalia V, Goldman M, Fan W, Yi QL, Huang M, Ndao M, Fearon MA: Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: seroprevalence of donors who answer 'no' to risk questions. Transfusion 2014; 54: 863-869.
21. Jackson Y, Gétaz L, Wolff H, Holst M, Mauris A, Tardin A, Sztajzel J, Besse V, Loutan L, Gaspoz JM, Jannin J, Albajar Vinas P, Luquetti A, Chappuis F: Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis 2010; 4:e592.
22. National Swiss Guidelines. https://sbsc-bsd.ch/dokuman/DokumenteBSD/Allgemeines/tabid/107/Default.aspx (last accessed April 19, 2016).
23. Cullen KA, Arguin PM: Malaria surveillance-United States, 2011 MMWR Surveillance Sum 2013; 62(suppl 5):1-17.
24. World Health Organization: World Malaria Report 2013. www.who.int/malaria/publications/world-malaria-report-2013/report/en/(last accessed April 19, 2016)
25. Anstey NM, Douglas NM, Poesporodjo JR, Price RN: Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol 2012; 80: 151-201.
26. Douglas NM, Anstey NM, Buffet PA, Poesporodjo JR, Yeo TW, White NJ, Price RN: The anemia of Plasmodium vivax malaria. Malaria J 2012; 11: 135.
27. Pathak S, Chandrashekhar M: Transfusion transmittable infections-seroprevalence among blood donors in a tertiary care hospital of Dehli. Asian J Transfus Sci 2013; 7: 116-118.
28. Frey-Wettstein M, Maier A, Markwalder K, Münch U: A case of transfusion transmitted malaria in Switzerland. Swiss Med Wkly 2001; 131: 320.
29. Slinger R, Giulivi A, Bodie-Collins M, Hindieh F, John RS, Sher G, Goldman M, Ricketts M, Kain KC: Transfusion-transmitted malaria in Canada. CMAJ 2001; 164: 377-379.
30. Kitchen AD, Barbara JA, Hewitt PE: Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines. Vox Sang 2005; 89: 77-80.
31. Kitchen AD, Chiodini PL: Malaria and blood transfusion. Vox Sang 2006; 90: 77-84.
32. Garraud O, Assal A, Pelletier B, Danic B, Kerleguer A, David B, Joussemet M, de Micco P: Overview of revised measures to prevent malaria transmission by blood transfusion in France. Vox Sang 2008; 95: 226-231.
33. Owusu-Ofori AK, Betson M, Parry CM, Stothard JR, Bates I: Transfusion-transmitted malaria in Ghana. Clin Infect Dis 2013; 56: 1735-1741.
34. Mungai M, Tegtmeier G, Chamberland M, Parise M: Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001; 344: 1973-1978.
35. Kitchen AD, Lowe PH, Lalloo K, Chiodini PL: Evaluation of a malarial antibody assay for use in the screening of blood and tissue products for clinical use. Vox Sang 2004; 87: 150-155.
36. Reesink HW, Panzer S, Wendel S, Levi JE, Ullum H, Ekblom-Kullberg S, Seifried E, Schmidt M, Shinar E, Prati D, Berzuini A, Ghosh S, Flesland ∅, Jeansson S, Zhiburt E, Piron M, Sauleda S, Ekermo B, Eglin R, Kitchen A, Dodd RY, Leiby DA, Katz LM, Kleinman S: The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang 2010; 98: 468-478.
37. Seed CR, Kee G, Wong T, Law M, Ismay S: Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimize transfusion transmitted malaria. Vox Sang 2010; 98:e182-192.
38. Leiby DA, Nguyen ML, Notari EP: Impact of donor deferrals for malaria on blood availability in the United States. Transfusion 2008; 48: 2222-2228.
39. O'Brien SF, Uzicanin S, Choquet K, Yi QL, Fan W, Goldman M: Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals. Blood Transfus 2013; 11: 580-584.
40. Markovic A, Ries J, Gottschalk J, Glauser A, Frey BM: Status report: lookback on transfused products of a T. cruzi positive blood donor. Clin Lab 2014; 8: 6.
41. Ries J, Komarek A, Gottschalk J, Brand B, Amsler L, Frey BM: A case of possible Chagas transmission by blood transfusion in Switzerland. Transfus Med Hemother 2016;DOI: 10.1159/000446264.
42. Orton SL, Stramer SL, Dodd RY, Alter MJ: Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV. Transfusion 2004; 44: 275-281.
43. Polizzotto MN, Wood EM, Ingham H, Keller AJ; Australian Red Cross Blood Service Donor and Product Safety Team: Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion 2008; 48: 55-63.
44. Van der Bij AK, Coutinho RA, Van der Poel CL: Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Transfusion 2006; 46: 1729-1736.
45. O'Brien SF, Chiavetta JA, Fan W, Xi G, Yi QL, Goldman M, Scalia V, Fearon MA: Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion 2008; 48: 755-761.
46. El Ghouzzi MH, Boiret E, Wind F, Brochard C, Fittere S, Paris L, Mazier D, Sansonetti N, Bierling P: Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening. Transfusion 2010; 50: 575-583.
47. Grant IH, Gold JW, Wittner M, Tanowitz HB, Nathan C, Mayer K, Reich L, Wollner N, Steinherz L, Ghavimi F, et al: Transfusion-associated acute Chagas disease acquired in the United States. Ann Intern Med 1989; 111: 849-851.
48. Nickerson P, Orr P, Schroeder ML, Sekla L, Johnston JB: Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann Intern Med 1989; 111: 851-853.
49. Cimo PL, Luper WE, Scouros MA: Transfusion-associated Chagas' disease in Texas: report of a case. Tex Med 1993; 89: 48-50.
50. Leiby DA, Lenes BA, Tibbals MA, Tames-Olmedo MT: Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999; 341: 1237-39.
51. Cardo LJ, Asher L: Transfusion medicine illustrated. Electron micrographic study of the removal of Trypanosoma cruzi from blood products by leukodepletion filters. Transfusion 2006; 46: 1067-1068.
52. Young C, Losikoff P, Chawla A, Glasser L, Forman E: Transfusion-acquired Trypanosoma cruzi infection. Transfusion 2007; 47: 540-544.
53. Flores-Chávez M, Fernández B, Puente S, Torres P, Rodríguez M, Monedero C, Cruz I, Gárate T, Canãvate C: Transfusional chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin Infect Dis 2008; 465:e44-47.
54. Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, Dodd RY: Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009; 49(suppl 2):1S-29S
55. Kessler DA, Shi PA, Avecilla ST, Shaz BH: Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center. Transfusion 2013; 53: 1083-87.
56. Van Voorhis WC, Barrett LK, Eastman RT, Alfonso R, Dupuis K: Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV. Antimicrob Agents Chemother 2003; 47: 475-479.
57. Singh Y, Sawyer LS, Pinkoski LS, Dupuis KW, Hsu JC, Lin L, Corash L: Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 2006; 46: 1168-1177.
58. Castro E, Gironés N, Bueno JL, Carrión J, Lin L, Fresno M: The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffycoat platelets. Transfusion 2007; 47: 434-441.
59. Fearon MA, Scalia V, Huang M, Dines I, Ndao M, Lagacé-Wiens P: A case of vertical transmission of Chagas disease contracted via blood transfusion in Canada. Can J Infect Dis Med Microbiol 2013; 24: 32-34.
60. Seed CR, Kee G, Wong T, Law M, Ismay S: Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimize transfusion transmitted malaria. Vox Sang 2010; 98:e182-192.
61. Schmidt M, Geilenkeuser WJ, Sireis W, Seifried E,Houfar K: Emerging pathogens-how safe is blood? Transfus Med Hemother 2014; 41: 10-17.